Home / Vancomycin / Canada
CA ATC J01XA01 · updated 2 Nov 2026
Vancomycin shortage in Canada
Is there a Vancomycin shortage in Canada?
Yes. As of 2 Nov 2026, 4 Vancomycin products are reported short in Canada, the first since 6 Sep 2017. The company estimate for the return is 31 Jan 2027. Main reason: increased demand.
Also short in United States, Germany, Italy, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (1x5g) | HOSPIRA HEALTHCARE CORPORATION | 6 Sep 2017 | not given | Other Other (Please describe in comments) |
| CA | JAMP-VANCOMYCIN (10 x 1 g) | JAMP PHARMA CORPORATION | 1 Apr 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (1G) | HIKMA CANADA LIMITED | 9 Oct 2026 | not given | Increased demand Demand increase for the drug |
| CA | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (500MG) | HIKMA CANADA LIMITED | 9 Oct 2026 | 31 Jan 2027 | Increased demand Demand increase for the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.